Wyden Statement on Public Charge Rule
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement after the Trump administration released new rules on “public charge” restrictions. “Donald Trump is continuing his profoundly destructive campaign against hardworking Americans and the economy,” Wyden said. “Not only is this approach a cruel pull of the rug out […]
Wyden Statement on the Epstein Bill’s Passage and Treasury’s Epstein File
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement on the passage of the Epstein bill and the bank records that remain hidden at the Treasury Department: “If Trump and Bondi are cooking up some harebrained scheme to slow-walk the release of the Epstein files or turn them […]
At Senate Finance Committee Hearing, Wyden Blasts Republicans Over Failure to Lower Health Care Costs for Americans
The Finance Committee is gathered this morning to discuss the health care crisis facing American families across the country. At this very moment, millions are logging on to Healthcare.gov and seeing premiums double, triple, or in the case of our guests from Oregon, even worse. The Republicans in charge of this Committee should have held […]
Wyden and Schumer Urge Trump to Stop Bait-and-Switch Affordability, Release Next Round of Medicare-Negotiated Drug Prices
As Trump Continues to Host Big Pharma Executives in the Oval Office to Tout Detail-Free “Deals,” Senators Call on Him to Release Lower Prices That Resulted From Democratic Medicare Drug Price Negotiation Law Text of the Letter (PDF) Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., Senate Minority Leader Chuck Schumer, D-N.Y., […]
Wyden Statement on Tariff Exemptions
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement on reports that Donald Trump will lower tariffs on some food items in response to spiraling prices: “After lying for months, Donald Trump has finally admitted that his tariffs are forcing Americans to pay more for groceries and making […]
Wyden Slams GOP Health Care Plan
I come to the floor today to discuss several recent floor developments. Yesterday, Senate Republicans started talking about big insurance companies and women’s health care. I’ve heard a lot of talk from Republicans about how the Affordable Care Act is just one big giveaway to big insurance companies. I’d ask any Republican who accuses Democrats […]
Wyden Statement on Musk’s Obscene Trillion-Dollar Pay Package
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement on the approval of Elon Musk’s trillion-dollar Tesla compensation package: “The fact that anyone could pursue or approve this gluttonous level of compensation is a sign of moral rot at the highest levels of our economy. There is something […]
Trumpcare is Gutting Americans’ Health Care
“Republicans are lying when they say the harms of this law will not be felt in the near term.” Monthly Tally of Hospitals, Patients, and Health Care Workers Getting Harmed Continues to Grow Text of Report Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., released the latest monthly installment of a report […]
Wyden Rips Treasury Report Ending Direct File
Washington, D.C. — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement on the Trump administration’s report announcing the end of the Direct File program, which gave taxpayers a free online option for filing their taxes directly with the IRS: “If an opportunity presents itself to stick it to working people […]
Wyden Statement on Trump Announcement on Obesity Drugs
Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement ahead of a planned announcement by Donald Trump at the White House, joined by pharmaceutical executives from Eli Lilly and Novo Nordisk. “The announcement of a lower price for Ozempic and other anti-obesity drugs is made possible by Medicare negotiation, […]